| 1 |
30431449 | Safe childbirth for a type 1 antithrombin-deficient woman with novel mutation in the SERPINC1 gene undergoing antithrombin concentrate therapy. | 2019 Jan |
1 |
| 2 |
18206177 | Antithrombin activity is inhibited by acrolein and homocysteine thiolactone: Protection by cysteine. | 2008 Feb 13 |
3 |
| 3 |
9521646 | Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin. | 1998 Mar 10 |
2 |
| 4 |
8874869 | A novel nonsense mutation in the antithrombin III gene (Cys-4-->stop) causing recurrent venous thrombosis. | 1996 Jul |
1 |
| 5 |
7512382 | Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region. | 1994 Apr 12 |
1 |
| 6 |
8037658 | Interaction of heparin with synthetic antithrombin III peptide analogues. | 1994 Jul 1 |
1 |
| 7 |
8176841 | [Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells]. | 1994 Apr |
1 |
| 8 |
8357789 | Transmission of conformational change from the heparin binding site to the reactive center of antithrombin. | 1993 Aug 24 |
1 |
| 9 |
8376590 | Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. | 1993 Sep |
1 |
| 10 |
1546950 | The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin. | 1992 Mar 1 |
3 |
| 11 |
2390061 | Re-formation of disulphide bonds in reduced antithrombin III. | 1990 Aug 1 |
24 |
| 12 |
6830263 | Localization of the disulfide bond in human antithrombin III required for heparin-accelerated thrombin inactivation. | 1983 Feb 15 |
3 |